Deficient expression of interleukin-10 receptor α chain in rheumatoid arthritis synovium: Limitation of animal models of inflammation

Arthritis and Rheumatism

Volumn 52, Issue 10, 2005, Pages 3315-3318

  Neidhart, Michel ^a   Jüngel, Astrid ^a   Ospelt, Caroline ^a   Michel, Beat A ^a   Gay, Renate E ^a   Gay, Steffen ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 10 RECEPTOR ALPHA CHAIN; UNCLASSIFIED DRUG;

ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE MODEL; FLOW CYTOMETRY; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; SYSTEMIC DISEASE; T LYMPHOCYTE ACTIVATION; TISSUE METABOLISM;

ANIMALS; ARTHRITIS, RHEUMATOID; DISEASE MODELS, ANIMAL; FIBROBLASTS; GENE EXPRESSION; GENE THERAPY; HUMANS; OSTEOARTHRITIS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-10; SYNOVIAL MEMBRANE;

EID: 26844511733     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21274     Document Type: Article

References (15)

1. Taylor PC. Anti-cytokines and cytokines in the treatment of rheumatoid arthritis. Curr Pharm Des 2003;9:1095-106.
2. Lubberts E, van den Berg WB. Potential of modulatory cytokines in the rheumatoid arthritis process. Drug News Perspect 2001;14: 517-22.
3. Bessis N, Doucet C, Cottard V, Douar AM, Firat H, Jorgensen C, et al. Gene therapy for rheumatoid arthritis. J Gene Med 2002;4: 581-91.
4. Slavin AJ, Tarner IH, Nakajima A, Urbanek-Ruiz I, McBride J, Contag CH, et al. Adoptive cellular gene therapy of autoimmune disease. Autoimmun Rev 2002;1:213-9.
5. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy: review of a new approach. Pharmacol Rev 2003;55:241-69.
6. Seifert M, Gruenberg BH, Sabat R, Donner P, Gruetz G, Volk HD, et al. Keratinocyte unresponsiveness towards interleukin-10: lack of specific binding due to deficient IL-10 receptor 1 expression. Exp Dermatol 2003;12:137-44.
7. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
8. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper, NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
9. McDonald KP, Pettit AR, Quinn C, Thomas GJ, Thomas R. Resistance of rheumatoid synovial dendritic cells to the immunosuppressive effects of IL-10. J Immunol 1999;163:5599-607.
10. Cairns AP, Crockard AD, Bell AL. Interleukin-10 receptor expression in systemic lupus erythematosus and rheumatoid arthritis. Clin Exp Rheumatol 2003;21:83-6.
11. Ritchlin C, Haas-Smith SA. Expression of interleukin 10 mRNA and protein by synovial fibroblastoid cells. J Rheumatol 2001;28: 698-705.
12. Tedgui A, Mallat Z. Anti-inflammatory mechanisms in the vascular wall [review]. Circ Res 2001;88:877-87.
13. Ospelt C, Neidhart M, Gay RE, Gay S. Synovial activation in rheumatoid arthritis. Front Biosci 2004;9:2323-34.
14. Ledeboer A, Binnekade R, Breve JJ, Bol JG, Tilders FJ, van Dam AM. Site-specific modulation of LPS-induced fever and interleukin-1β expression in rats by interleukin-10. Am J Physiol Regul Integr Comp Physiol 2002;282:R1762-72.
15. Van Roon J, Wijngaarden S, Lafeber FP, Damen C, van de Winkel J, Bijlsma JW. Interleukin 10 treatment of patients with rheumatoid arthritis enhances Fc γ receptor expression on monocytes and responsiveness to immune complex stimulation. J Rheumatol 2003;30:648-51.